摘要
目的研究经导管肝动脉化疗栓塞术(TACE)、经皮肝穿刺无水酒精注射术(PEI)及TACE联合PEI3种介入治疗手段治疗原发性肝癌的临床疗效。方法选择2006年3月～2008年3月本院接诊的120例原发性肝癌患者进行研究。按照随机数表法,随机分为TACE组、PEI组以及TACE+PEI组,每组各40例。分别采用相应治疗措施对患者进行治疗。结果 TACE+PEI组患者治疗的临床总有效率(95%)明显高于TACE组(70%)和PEI组(30%),3组比较差异有统计学意义(P<0.05);TACE+PEI组患者的5年生存率状况明显优于TACE组和PEI组,3组比较差异有统计学意义(P<0.05)。结论采用TACE+PEI联合介入治疗原发性肝癌,效果良好,明显优于单纯采用TACE或PEI治疗。
Objective To study the clinical efficacy of TACE,PEI and TACE combined with PEI the three interventional procedure for primary hepatic carcinoma. Methods 120 patients with primary hepatic carcinoma from March 2006 to March 2008 in our hospital were studied.They were randomly divided into TACE group,PEI group,and TACE＋ PEI group in accordance with the law of the random number table,each group of 40 cases.Appropriate therapeutic measures were used to treat patients. Results The treatment of patients with clinical total efficiency in TACE ＋PEI group （95%） was significantly higher than that of the TACE group （70%） and PEI （30%）,the three groups was statistically significant （P＆lt;0.05）;The 5-years survival of the patient’s condition in TACE＋PEI group was significantly better than that of the TACE group and the PEI group,the three groups was statistically significant （ P＆lt;0.05）. Conclusion Using conventional TACE＋PEI in combined interventional treatment for primary liver cancer patients,the effect is good,it is better than using conventional TACE or PEI treatment alone.
出处
《中国当代医药》
2013年第21期17-18,共2页
China Modern Medicine
关键词
原发性肝癌
介入治疗
临床疗效
Primary hepatic carcinoma
Intervention procedure
Clinical efficacy
